An Excellent Educational Seminar in
Exciting Rio de Janeiro
&
Fascinating Buenos Aires



Information for Latin American CE Program

Subject

Managing Hypertension and the Comorbidities of Dyslipidemia, Diabetes and Metabolic Syndrome.

 

Statement of Need:

Hypertension is the most common reason for the use of prescription drugs in the United States. Data from the Centers for Disease Control indicates a prevalence of 30.1% in adults over age 20 (approximately 65 million people). Hypertension is associated with a number of serious complications, including cardiovascular disease, heart failure, stroke, chronic renal insufficiency and renal failure. It is estimated that only 34% of persons with hypertension have their blood pressure under control. Hypertension is only one of the disease states that will increase in prevalence with obesity.

Dyslipidemia, the metabolic syndrome, and diabetes, will follow closely on the coat-tails of obesity. Among adults, the prevalence of diagnosed diabetes has increased 61% since 1991, and it is projected to more than double by 2050.

 

Learning Objectives:

At the conclusion of this program, the participant will be able to:

1.
Analyze recent data on prevalence, diagnosis, and treatment of hypertension and the comorbidities of dyslipidemia, diabetes, and metabolic syndrome for a better awareness of this cluster of disorders.
2.
Propose strategies for the earlier diagnosis of diabetes, metabolic syndrome, and sub-clinical vascular disease, with the goal of preventing events.
3.
Assess global risk assessment, and its implications for treating hypertension, dyslipidemia, and other cardiovascular risk factors in patients at risk.
4.
Evaluate guideline-approved screening and risk assessment strategies for the diabetic patient who does not have a history of avert cardiovascular disease.

 

Program Agenda:

Breakfast Sessions

What is the Evidence for Aggressive LDL Lowering?
Why is the Systolic Hypertension a Significant Risk?
What is the Evidence for Triglyceride Lowering?
What is a Normal Fasting Blood Sugar?
Role for HDL Raising Strategies?
Role for Stringent Blood Glucose Control During ACS?

Evening Sessions

Better Hyperlipidemia Management
Optimum Hypertension Management
Managing the Metabolic Syndrome
A Pathway Approach to the Management of Type 2 Diabetes
Insulin Therapy Benefits and Strategies for Achieving Glycemic Control
Pulling it All Together in Clinical Practice

 

Registration

Pinnacle CME Tours
Email: info@pinnaclecmetours.com

Download the Registration Form
CLICK HERE

 

CME Fee per participant (in addition to the tour) - $575

 

 
www.pinnaclecmetours.com, www.pinnacleluxurytours.com, e-mail: info@pinnaclecmetours.com


CST# 2081865-40